期刊
NEUROSURGERY
卷 92, 期 1, 页码 68-74出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1227/neu.0000000000002164
关键词
Prophylactic antiepileptic drug; Seizures; Brain tumor; Keppra; Levetiracetam
This study aimed to compare the side effects of prophylactic levetiracetam treatment for 1 week versus 6 weeks in patients undergoing surgical resection. The results showed that there was no significant neurotoxicity or depression in patients treated with levetiracetam for either duration, and the incidence of seizure after surgery was low.
BACKGROUND:Levetiracetam is commonly used as a prophylactic antiseizure medication in patients undergoing surgical resection of brain tumors.OBJECTIVE:To quantitate side effects experienced in patients treated with 1 week vs 6 weeks of prophylactic levetiracetam using validated measures for neurotoxicity and depression.METHODS:Patients undergoing surgical resection of a supratentorial tumor with no seizure history were randomized within 48 hours of surgery to receive prophylactic levetiracetam for the duration of either 1 or 6 weeks. Patients were given oral levetiracetam extended release 1000 mg during the first part of this study. Owing to drug backorder, patients enrolled later in this study received levetiracetam 500 mg BID. The primary outcome was the change in the neurotoxicity score 6 weeks after drug initiation. The secondary outcome was seizure incidence.RESULTS:A total of 81 patients were enrolled and randomized to 1 week (40 patients) or 6 weeks (41 patients) of prophylactic levetiracetam treatment. The neurotoxicity score slightly improved in the overall cohort between baseline and reassessment. There was no significant difference between groups in neurotoxicity or depression scores. Seizure incidence was low in the entire cohort of patients with 1 patient in each arm experiencing a seizure during the follow-up period.CONCLUSION:The use of prophylactic levetiracetam did not result in significant neurotoxicity or depression when given for either 1 week or 6 weeks. The incidence of seizure after craniotomy for tumor resection is low regardless of duration of therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据